Diligence memo · auto-generated · as of July 2, 2026

California Cultured Inc.

California Cultured Inc. looks fair against its niche peers and is quiet on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

California Cultured Inc. operates in Biotechnology, based in WEST SACRAMENTO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

California Cultured Inc. has raised $16M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $8.1M on 2024-03-26.

Most recent recorded round closed around 2024-03-26.

Valuation (modeled)modeled

Provath models California Cultured Inc. at approximately $48M (range $8.8M–$111M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.09× the median modeled value of Series A Biotechnology companies in 2022–2024 (303 peers) — value vs value, same stage and era. Within the normal band (109% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 19 months.

Last raise 2.3 yr ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round stepped up 1.0× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 64% of Biotechnology peers (4293 compared).

Modeled value ranks above 44% of those peers.

Closest niche peers: GeoVax Labs, Inc., Cellinfinity Bio Holding Company, LLC, Adient Medical, Inc., Entegrion Inc, BCD Bioscience, Inc..

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.